Abstract
Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have